In these roles, Mr Holtz will be responsible for oversight of the controller’s group, treasury, risk management and information technology reporting to Thomas Gardner, chairman and CEO of Nucryst.
Before joining Nucryst, Mr Holtz served as financial management consultant for various start-up companies, including Virium Pharmaceuticals.
Mr Gardner said: “David has a proven track record for helping the organizations he has worked for to generate superior value by supporting the successful execution of their business strategies. The breadth and depth of his experience in finance, accounting, compliance, cost control and business development will be of noteworthy value at this time.”